toxicity, with an increased risk of carcinogenesis. [12] [13] [14] [15] The hematologic toxicity of benzene poisoning has been well documented in the literature. 3, 15, 16 It is well established that benzene exposure can induce blood disorders leading to hematopoietic malignancies and other cancers. 13, 14, [17] [18] [19] [20] Moreover, several adverse respiratory effects have been reported in humans following exposure to benzene. These effects include pulmonary edema, acute granular tracheitis, laryngitis, bronchitis, and massive lung hemorrhage. [21] [22] [23] In addition, neurological abnormalities were reported in subjects with benzene poisoning. 24, 25 Evidence also indicates that exposure to volatile petroleum constituents such as benzene can affect a variety of organs such as the liver, kidney, and brain. [26] [27] [28] In 2009, the International Agency for Research on Cancer reconfirmed that benzene exposure causes acute myeloid leukemia 29 ; however, its relationship with other lymphocytic malignancies remains unknown. Decades of work using in vitro and in vivo studies on benzene metabolism, pharmacokinetics, hematologic toxicity, cytotoxicity, genotoxicity, and carcinogenicity are starting to converge on a small set of overlapping hypotheses about the most probable biological mechanisms of benzene toxicity and carcinogenicity. 30, 31 Possible mechanisms underlying benzeneinduced pathologies include the generation of free radicals leading to oxidative stress, immune system dysfunction, and decreased immune surveillance. 3 The toxic effects of benzene are thought to arise from its metabolism, which proceeds along several lines leading to numerous metabolites including phenol, benzoquinone, muconaldehydes, hydroquinone, and catechol. 32 Of these various metabolites, benzoquinone and the muconaldehydes are regarded as the most toxic chemicals with significant health effects.
Recently, a massive amount of toxic chemicals were released into the skies during a flaring incident at the BP refinery in Texas City, TX. 33, 34 The release of toxic chemicals from the BP refinery began on April 6, 2010 and lasted 40 days until May 16, 2010 . It is estimated that more than 226,796 kg (500,000 lb) of toxic chemicals, including more than 7,711 kg (17,000 lb) of benzene were released into the air while BP was fixing the problem. [33] [34] [35] The flaring incident at the refinery may have an enormously negative health impact on the residents of Texas City and surrounding communities. Galveston County District Clerk's Office records indicate that more than 50,000 people are presumed to have been exposed to the benzene and other toxic chemicals as a result of the emission event at the BP refinery.
To investigate the negative health impacts, we identified a cohort of subjects who were exposed to a sustained release of high levels of benzene from the BP's flaring incident daily during 6 weeks, spanning from April 6 through May 16, 2010 . In this pilot study, we assessed the health consequences of environmental exposure of benzene and other toxic chemicals in a group of subjects who were exposed to the toxic release from the BP's flaring incident. In particular, the clinical outcomes of the subjects exposed to benzene and other chemicals of the toxic release were evaluated and compared to a group of subjects who were not exposed to benzene.
M Ma at te er ri ia al ls s a an nd d M Me et th ho od ds s
This retrospective study was approved by an institutional review board. Subjects who underwent clinical as well as laboratory evaluations between June 2010 and October 2012 were included. Demographic and clinical laboratory data were collected retrospectively using medical charts and analyzed.
Subjects included in this study were referred to us for medical evaluation by the subjects' legal representatives. A written consent was obtained from the subjects' legal representatives. The study was conducted according to the ethical principles of the Declaration of Helsinki. To comply with the Health Insurance Portability and Accountability Act (HIPAA), confidentiality of information was secured by using text encryption, password protection, and limited personnel involvement. In addition, the personal information of the participating subjects was redacted to exclude any identifiable personal information.
I Id de en nt ti if fi ic ca at ti io on n a an nd d s se el le ec ct ti io on n o of f s su ub bj je ec ct ts s Subjects exposed to benzene. As shown in Figure 1 , based on the residential addresses and zip codes, subjects who resided in the path of the toxic chemical release from the BP refinery emission event were identified and included in the study. All subjects in this group experienced involuntary exposure to benzene for 40 days following the BP refinery flaring incident.
Unexposed subjects. Subjects in the unexposed group were drawn from a primary care clinic which was located approximately 30 miles away from the BP refinery in Texas City, TX. These unexposed subjects included in the study had visited the clinic for a routine wellness checkup. The unexposed subjects were selected randomly by the primary care physician and any identifiable personal information was redacted. Demographic and clinical data were collected from the subjects' medical charts and included in this study. Laboratory tests on blood and urine samples of the benzene exposed and unexposed subjects were performed by an accredited laboratory facility (LabCorp, Laboratory Corporation of America, Houston, TX). Hematologic analysis was performed using a Sysmex XE-2100 (Sysmex Corp. Kobe, Japan) hematology analyzer. 36 The hematologic analysis consisted of hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, white blood cell (WBC) counts, and platelet counts. Liver toxicity was assessed by measuring alkaline phosphatase (ALP), aspartate amino transferase (AST), and alanine amino transferase (ALT) levels in the serum. In addition, serum beta-2 microglobulin was assessed in the benzene exposed subjects. Urinary phenol was assessed as a benzene metabolite using Agilent 5980 GC system (Agilent Technologies, Wilmington, DE) in benzene exposed subjects. All analyses were conducted by LabCorp who was unaware of the subjects' exposure status.
S St ta at ti is st ti ic cs s
Data from all laboratory examinations in this study were systematically collected from the subjects' medical charts and subjected to statistical analysis. Descriptive statistics were used to assess patient demographics which included means and standard deviations for each group. Variables included were WBC, platelets, hemoglobin, hematocrit, creatinine, BUN, AST, ALT, beta-2 microglobulin, and urinary phenol. Student's t test was used to assess the differences between the benzene exposed and unexposed groups. The significance level was predetermined at an alpha level of 0.05.
R Re es su ul lt ts s
In this pilot study, a total of 200 subjects (benzene exposed, n ϭ 100 and unexposed, n ϭ 100) were included. Subjects exposed to benzene were residing geographically proximal to the source of the toxic chemicals release by the BP refinery ( Figure 1 ). Another group of unexposed subjects (n ϭ 100) living 30-40 miles geographically away from the BP refinery were compared to the exposed subjects. The patients' demographics are given in Table 1 . Male subjects accounted for 36 percent and 57 percent in the unexposed and exposed groups, respectively. There were 64 (64 percent) and 43 (43 percent) female subjects in the unexposed and exposed groups, respectively. Among 100 benzene exposed subjects, 73 (73 percent) were adults (>18 years) and 27 (27 percent) were children (<18 years). However, no children (<18 years) were present in the unexposed group. The median age of the adult subjects was 53.0 (18-90) and 38.0 (19-86) years in the unexposed and exposed groups, respectively. The median age of children exposed to benzene was 8.0 (3-16) years. The data in Table 2 indicate the normal range of values for various hematologic and hepatic parameters that were assessed in the study. The results presented in Table 3 show the differences in hematologic and hepatic markers between the subjects exposed and unexposed to benzene. The mean WBC count (ϫ10 3 per L) was significantly higher in the benzene exposed group compared with the unexposed group (8.6 Ϯ 5.4 vs 6.5 Ϯ 2.0, p ϭ 0.0003). Similarly, the mean platelet count (ϫ10 3 per L) in the benzene exposed group was significantly elevated compared with the unexposed group (291.3 Ϯ 82.7 vs 264.1 Ϯ 74.0, p ϭ 0.0076).
The mean hemoglobin (g/dL) levels increased marginally but not significantly in the benzene exposed group compared with the unexposed group (13.6 Ϯ 1.8 vs 13.9 Ϯ 1.5, p ϭ 0.0641. Similarly, the percentage of hematocrit increased marginally but not significantly among the benzene exposed subjects compared with the unexposed subjects (41.7 Ϯ 4.8 vs 40.8 Ϯ 4.2, p ϭ 0.0719). Conversely, the benzene exposed subjects had significantly decreased BUN (mg/dL) compared with the unexposed subjects (12.8 Ϯ 4.2 vs 15.4 Ϯ 7.1, p ϭ 0.0007). Similarly, the serum creatinine levels (mg/dL) were significantly decreased in the benzene exposed group compared with the unexposed group (0.8 Ϯ 0.2 vs 0.9 Ϯ 0.3, p ϭ 0.0146).
Compared with the unexposed subjects, benzene exposed subjects had significantly elevated levels of ALP (65.4 Ϯ 23.6 vs 121.2 Ϯ 73.7 IU/L, p ϭ 0.000). The mean AST levels were significantly higher in the benzene exposed group compared with the unexposed group (23.4 Ϯ 11.8 vs 19.5 Ϯ 8.9, p ϭ 0.0089). The mean serum ALT levels was increased marginally but not significantly in the benzene exposed group compared with the unexposed group (24.2 Ϯ 14.2 vs 21.1 Ϯ 13.6, p ϭ 0.0741).
The findings presented in Table 4 represent the differences in hematologic and hepatic markers between the exposed and unexposed subjects to benzene according to their gender. The mean WBC count (ϫ10 3 per L) was significantly higher in male (8.8 Ϯ 6.7 vs 6.6 Ϯ 2.2, p ϭ 0.0344) and female (8.3 Ϯ 3.1 vs 6.5 Ϯ 1.9, p ϭ 0.0000) subjects exposed to benzene compared with the unexposed group. Similarly, the mean platelet count (ϫ10 3 per L) in male (267.7 Ϯ 73.8 vs 234.8 Ϯ 65.2, p ϭ 0.015) and female (322.6 Ϯ 84.2 vs 281.1 Ϯ 79.2, p ϭ 0.005) subjects exposed to benzene was significantly elevated compared with the unexposed group. The mean hemoglobin (g/dL) levels did not differ significantly in the male or female subjects between the benzene exposed and unexposed groups. While male subjects had similar hematocrit (percent) levels, female subjects in the exposed group had significantly reduced hematocrit (percent) levels compared with the unexposed group (37.8 Ϯ 3.9 vs 40.0 Ϯ 5.0, p ϭ 0.010). BUN (mg/dL) was also significantly lower in male and female subjects in the benzene exposed group compared with the unexposed group.
www.disastermedicinejournal.com 1 1 7 7 3 3 The mean serum ALP levels (IU/L) were significantly elevated in male (128.6 Ϯ 85.7 vs 73.6 Ϯ 31.7, p ϭ 0.004) and female (129.0 Ϯ 84.1 vs 64.9 Ϯ 19.6, p ϭ 0.000) subjects in the benzene exposed group compared with the unexposed group. Although the serum AST levels (IU/L) did not differ statistically in male subjects, female subjects had significantly higher levels of AST (IU/L) in the exposed group compared with the unexposed group (20.9 Ϯ 7.3 vs 18.2 Ϯ 7.0, p ϭ 0.038). No gender differences were observed in the serum levels of ALT (IU/L) among exposed and unexposed subjects to benzene ( Table 4) .
As no children were present in the unexposed group, we had an option to compare the health effect of benzene exposure among adult subjects in the exposed and unexposed groups. The results in Table 5 indicate the differences in study outcomes between exposed and unexposed adult subjects. Adult subjects in the exposed group had significantly altered levels of WBC counts, BUN, and serum levels of ALP, AST, and ALT enzymes compared with those in the unexposed group.
To further evaluate if the subjects age (children vs adults) contributed to any observed deleterious health effects of benzene exposure, a subgroup analysis was performed among benzene exposed subjects. The results presented in Figure 2 reveal the differences in health consequences of benzene exposure among children (<18 years, n ϭ 27) and adults (>18 years, n ϭ 73). No significant differences were observed in the mean WBC count between children and adult subjects exposed to benzene. Compared with children, adult subjects in the exposed group had significantly higher levels of hemoglobin, hematocrit, creatinine, ALT, beta-2-microglobulin, and urinary phenol. Conversely, adult subjects in the exposed group had significantly reduced platelet counts and ALP levels compared with the pediatric subjects. The mean AST levels were statistically similar between the exposed children and adult subjects.
Urinary phenol is considered an index of benzene exposure. Thus, we assessed the phenol excretion in the urine of benzene exposed patients. The mean urinary phenol in the benzene exposed subjects was 22.7 mg/L. Subgroup analysis of our findings showed that children (<18 years) had significantly lower phenol levels in the urine compared with adults. D Di is sc cu us ss si io on n Currently, there is no clear evidence available indicating threshold levels below which benzene does not cause hematologic toxic effects in humans. 37 In this retrospective pilot study, we evaluated the health consequences of ambient benzene exposure resulting from the BP flaring incident in Texas City, TX. [33] [34] [35] The clinical outcome from benzene exposed subjects was evaluated and compared with that from unexposed subjects.
The findings of the present study reveal that benzene exposure may play an important role in the development of hematologic and hepatic toxicity. The WBC and platelet counts were significantly higher in benzene exposed subjects compared with those of the www.disastermedicinejournal.com 1 1 7 7 5 5 unexposed subjects. Hemoglobin and hematocrit levels remained similar between the benzene exposed subjects as compared with the unexposed subjects. These findings are consistent with most previous reports of benzene hematologic toxicity. A study by Liu et al. 38 compared the hematologic toxicity of benzene in exposed and unexposed subjects. The study divided the subjects into the following three groups: unexposed, low exposed, and highly exposed. WBC, lymphocytes, monocyte, and eosinophil counts and hemoglobin levels were significantly higher in benzene exposed subjects compared with unexposed subjects. Similarly, Ray et al. 39 reported significantly increased WBC and platelet counts in subjects exposed to benzene compared with the controls. However, in subjects exposed to benzene, the hemoglobin levels were found to be significantly reduced compared with the unexposed subjects. In contrary, other studies found significant decrease in WBC and platelet counts in benzene exposed subjects compared with unexposed subjects. 1, 40, 41 However, Ceresa et al. 42 reported that thrombocytopenia was not a constant finding in the majority of cases resulting from chronic benzene exposure. 43 Most organic solvents including benzene are well-known hepatotoxic compounds. AST and ALT are the enzymes most often measured for liver functions evaluation. 44 These enzymes have been reported to be affected by exposure to benzene. 45 In the present study, the levels of AST and ALT were found to be elevated among subjects exposed to benzene compared with the unexposed subjects. Further, in subjects exposed to benzene, the levels of ALP were found to be increased compared with the unexposed subjects. These serum enzyme levels have been considered indicators of hepatic damage. Phosphatases, amino transferases, and dehydrogenases are important enzymes in biological processes. They are responsible for detoxification, metabolism, and biosynthesis of energetic macromolecules for different essential functions. Any interference in these enzymes leads to biochemical impairment and lesions in the tissue and cellular function. They are considered as specific indicators for hepatic dysfunction and damage. 46 The increased levels of these enzymes found in this study are consistent with most previous reports of benzene hepatotoxicity in clinical and preclinical studies. 27, 47, 48 The increase in the levels of these hepatic enzymes in the serum may be due to the impairment in the function of hepatic tissues following exposure to benzene, thereby the liberation of these enzymes into the circulation. Furthermore, there were also increased levels of serum ALP, an enzyme often used to measure hepatic and biliary tract function. 49, 50 The increase in the serum levels of this enzyme suggested biliary tract dysfunction in the subjects exposed to benzene.
To further understand the effect of the benzene exposure by gender and age (adults or children), we compared the outcomes by age or gender between the exposed and unexposed subjects to benzene. As there were no children in the unexposed group, we could only compare the outcomes for adults between the exposed and unexposed groups. Results from this study demonstrated that adult subjects in the exposed group could be at a significantly higher risk of tissue or organ toxicity compared with the unexposed adults.
Although the results of the present study show both men and women were affected by the benzene exposure, the magnitude of significance appears to be higher in exposed women in comparison to exposed men. These findings suggest that women may be at a higher risk for certain effects of benzene exposure than men. This could be explained based on the differences in the metabolism of benzene and possibly the presence of a higher body fat percentage in women compared with men. In general, women tend to have a higher blood/air partition coefficient and maximum velocity of metabolism for benzene than men. A pharmacokinetic modeling study by Brown et al. 51 suggests that physicochemical gender differences result in women metabolizing 25 percent more benzene than men when subjected to the same exposure scenario despite benzene blood concentration levels are generally higher in men.
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Figure 2. Differences in health consequences of benzene exposure among children (younger than 18 years, n ϭ ϭ 27) and adult (older than 18 years, n ϭ ϭ 73) subjects. Compared with children, adult exposed subjects had significantly higher levels of hemoglobin, hematocrit, creatinine, alanine amino transferase, beta-2-microglobulin, and urinary phenol. Whereas, platelet counts and alkaline phosphatase (ALP) levels were decreased significantly in adults subjects compared with children after benzene exposure. AST, aspartate amino transferase and ALT, alanine amino transferase.
Historically, urinary phenol has been used as an index of benzene exposure. [52] [53] [54] Therefore, in this study, we assessed the phenol excretion in the urine of benzene exposed subjects. In general, experts perceive that subjects who were not exposed to benzene excrete undetectable levels of phenol in the urine. In the current study, we also lack the information on urinary excretion of phenol for unexposed subjects to benzene to establish baseline values and to ascertain the differences from exposed subjects to benzene. However, we found considerable amounts of phenol excreted in the urine indicating the circulation of benzene in exposed subjects. Furthermore, the subanalysis indicated that children (<18 years) had significantly lower phenol in the urine compared with adults (Ն18 years).Additional studies are required to determine the association of urinary excretion of phenol in relation to observed hematologic and hepatic changes in those subjects exposed to benzene.
A limitation of this study was that it was conducted using cross-sectional design. It was difficult to infer a causality using such a study design because the clinical outcomes were measured at one time point after exposure to benzene. Moreover, the study was not designed or powered to detect significant differences between subjects exposed and unexposed to benzene. Therefore, given the cross-sectional nature of the study design, the findings of the study should be interpreted with caution.
C Co on nc cl lu us si io on n
In conclusion, the findings of this study indicate that the environmental benzene exposure that resulted from the BP's flaring incident may adversely affect the hematologic indices and liver functions of the exposed subjects. The observed hematologic alterations include increased WBC, platelet counts, and decreased BUN and creatinine in benzene exposed subjects compared with unexposed subjects. Elevated levels of ALP, AST, and ALT indicate altered liver functions in subjects exposed to benzene. However, it must be emphasized that as this study was not a controlled trial, the observed findings could be influenced by the compounding factors that are inherent to the study. These included cross-sectional study design, lack of baseline data before exposure, and the retrospective nature of this study. Moreover, the procedures used in this study did not follow a predefined scheme, which may have biased the interpretation of the results; in particular, the variables included in this study could not be analyzed in a controlled way. A large cohort study involving approximately 4,000 subjects is underway to further understand the health consequences of ambient benzene exposure of toxic chemicals including benzene and carbon monoxide that were released into the air due to the BP's flaring incident in Texas City, TX.
